Pharmaceutical Executive-04-01-2010

Pharmaceutical Executive
Features

May 11, 2010

Pfizer's Specialty Product Business Unit leader discusses his vision for the drug giant's specialty business; now the largest in the industry.

Pharmaceutical Executive

As head of GSK's North American pharma, Deirdre Connelly has the daunting challenge of trying to turn around the sluggish US market. If she succeeds, Connelly may find herself auditioning as the first female Big Pharma CEO.

Issue PDF
Pharmaceutical Executive

April 01, 2010

HBA Woman of the Year

Pharmaceutical Executive

Re-examining service provider roles can bring safety and speed on the road to registration.

From the Editor
Pharmaceutical Executive

April 01, 2010

Success in this harsh climate depends on seeing business through the eye of the customer

Pharmaceutical Executive
Back Page

April 01, 2010

Big thinker Bernard Munos delivers the goods.

Columns
Pharmaceutical Executive

April 01, 2010

Companies need to employ 3D analysis to assess markets, stakeholders, and competitors

Pharmaceutical Executive
Washington Report

April 01, 2010

FDA Commissioner Margaret Hamburg looks to bolster the agency's scientific expertise.

Pharmaceutical Executive
Columns

April 01, 2010

Dutch pharma releases the same drug as a brand and a generic. Will this two-pronged attack work?

Pharmaceutical Executive
Features

April 01, 2010

Cognitive enhancement is a $20 billion market of aging Boomers, cramming students, global travelers, and battling soldiers. What's pharma going to do about it.